Moleculin Biotech
MBRX
MBRX
21 hedge funds and large institutions have $925K invested in Moleculin Biotech in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$217 | |
| 2 | +$96 | |
| 3 | +$85 | |
| 4 |
BlackRock
New York
|
+$45 |
| 5 |
JPMorgan Chase & Co
New York
|
+$15 |
Top Sellers
| 1 | -$44.7K | |
| 2 | -$13.7K | |
| 3 | -$7.59K | |
| 4 |
Renaissance Technologies
New York
|
-$3.06K |
| 5 |
Millennium Management
New York
|
-$1.39K |